Mutation-Derived Tumor Antigens: Novel Targets in Cancer Immunotherapy

被引：0
|
作者：
Finnigan, John P. [1 ]
Rubinsteyn, Alex [2 ]
Hannmerbacher, Jeffrey [2 ]
Bhardwaj, Nina [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA
来源：
ONCOLOGY-NEW YORK | 2015年 / 29卷 / 12期
关键词：
CYTOLYTIC T-LYMPHOCYTES; EXOME ANALYSIS REVEALS; CTLA-4; BLOCKADE; POINT MUTATION; PD-1; GENE ENCODES; PHASE-II; MELANOMA; CELLS; EPITOPES;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：970 / +
页数：5
相关论文
共 50 条
  • [1] Mutation-Derived Neoantigens for Cancer Immunotherapy
    Castle, John C.
    Uduman, Mohamed
    Pabla, Simarjot
    Stein, Robert B.
    Buell, Jennifer S.
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [2] Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies
    Aparicio, Belen
    Theunissen, Patrick
    Hervas-Stubbs, Sandra
    Fortes, Puri
    Sarobe, Pablo
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [3] MAGE-A antigens as targets for cancer immunotherapy
    Schooten, Erik
    Di Maggio, Alessia
    Henegouwen, Paul M. P. van Bergen En
    Kijanka, Marta M.
    CANCER TREATMENT REVIEWS, 2018, 67 : 54 - 62
  • [4] Human Tumor Antigens and Cancer Immunotherapy
    Vigneron, Nathalie
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [5] Cancer-Testis Antigens: Potential Targets for Cancer Immunotherapy
    Ghafouri-Fard, Soudeh
    Modarressi, Mohammad-Hossein
    ARCHIVES OF IRANIAN MEDICINE, 2009, 12 (04) : 395 - 404
  • [6] Comprehensive Analysis of the Prognostic Signature of Mutation-Derived Genome Instability-Related lncRNAs for Patients With Endometrial Cancer
    Liu, Jinhui
    Cui, Guoliang
    Ye, Jun
    Wang, Yutong
    Wang, Can
    Bai, Jianling
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [7] Biosignals modulated by tumor-associated carbohydrate antigens - Novel targets for cancer therapy
    Furukawa, Koichi
    Hamamura, Kazunori
    Aixinjueluo, Wei
    Furukawa, Keiko
    INTEGRATED MOLECULAR MEDICINE FOR NEURONAL AND NEOPLASTIC DISORDERS, 2006, 1086 : 185 - 198
  • [8] Tumor neoantigens: building a framework for personalized cancer immunotherapy
    Gubin, Matthew M.
    Artyomov, Maxim N.
    Mardis, Elaine R.
    Schreiber, Robert D.
    JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (09) : 3413 - 3421
  • [9] Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set
    Roszik, Jason
    Haydu, Lauren E.
    Hess, Kenneth R.
    Oba, Junna
    Joon, Aron Y.
    Siroy, Alan E.
    Karpinets, Tatiana V.
    Stingo, Francesco C.
    Baladandayuthapani, Veera
    Tetzlaff, Michael T.
    Wargo, Jennifer A.
    Chen, Ken
    Forget, Marie-Andree
    Haymaker, Cara L.
    Chen, Jie Qing
    Meric-Bernstam, Funda
    Eterovic, Agda K.
    Shaw, Kenna R.
    Mills, Gordon B.
    Gershenwald, Jeffrey E.
    Radvanyi, Laszlo G.
    Hwu, Patrick
    Futreal, P. Andrew
    Gibbons, Don L.
    Lazar, Alexander J.
    Bernatchez, Chantale
    Davies, Michael A.
    Woodman, Scott E.
    BMC MEDICINE, 2016, 14
  • [10] Intracellular Tumor-Associated Antigens Represent Effective Targets for Passive Immunotherapy
    Noguchi, Takuro
    Kato, Takuma
    Wang, Linan
    Maeda, Yuka
    Ikeda, Hiroaki
    Sato, Eiichi
    Knuth, Alexander
    Gnjatic, Sacha
    Ritter, Gerd
    Sakaguchi, Shimon
    Old, Lloyd J.
    Shiku, Hiroshi
    Nishikawa, Hiroyoshi
    CANCER RESEARCH, 2012, 72 (07) : 1672 - 1682
12345